Takeda Teams With Evozyne On Protein Design For Gene Therapy
Executive Summary
Deal Snapshot: Building on a 2021 tie-up between Takeda and the Paragon start-up, Evozyne will seek novel protein sequences for inclusion in gene therapies for rare disease indications.